Table 1.
Age | N subjects (M/F) | Nobese | Nhyper- cholesterole mia |
Nhyper- lipidemia |
Nheart disorder |
Ndiabetes | Nhypertension | Nanti- hypertensive meds |
Nad | Nmd |
---|---|---|---|---|---|---|---|---|---|---|
28–30 | 19 (9/10) | 10 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 3 |
31–40 | 117 (56/61) | 32 | 8 | 3 | 0 | 3 | 18 | 3 | 8 | 18 |
41–50 | 92 (30/62) | 32 | 22 | 6 | 2 | 19 | 16 | 8 | 7 | 27 |
51–60 | 68 (22/46) | 26 | 23 | 4 | 4 | 24 | 15 | 10 | 2 | 24 |
61–70 | 54 (22/32) | 16 | 27 | 10 | 7 | 32 | 18 | 10 | 2 | 9 |
71–85 | 19 (8/11) | 6 | 10 | 3 | 3 | 12 | 7 | 5 | 0 | 5 |